Opa1 Overexpression Protects from Early-Onset Mpv17 −/−-Related Mouse Kidney Disease

Overview of attention for article published in Molecular Therapy, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 20 X posts from 19 X users, with an upper bound of 66,400 followers.

RT @MitoAging: OPA1 as a therapy tool! Congrats to the authors! https://t.co/Hmc2SIWt06

NEW #LMBpublications Opa1 Overexpression Protects from Early-Onset Mpv17-/--Related Mouse Kidney Disease.https://t.co/ec4LYB4xTy

RT @CarloViscomi: Opa1 overexpression protects from early onset Mpv17-/--related mouse kidney disease. https://t.co/uml4NrcHVB

RT @CarloViscomi: Opa1 overexpression protects from early onset Mpv17-/--related mouse kidney disease. https://t.co/uml4NrcHVB

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 16 additional X posts.